1. Hewett JA, Roth RA: Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacological Reviews 45(4): 381-411, 1993.
2. Margaretten W, McKay DG, Phillips LL: The effect of heparin on endotoxin shock in the rat. Am J Pathol 51: 61-68, 1967.
3. Pearson JM, Schultze AE, Jean PA, Roth RA: Platelet participation in liver injury from gram-negative bacterial lipopolysaccharide in the rat. Shock 4 (3): 178-186, 1995.
4. Suzuki M, Suematsu M, Miura S, Oshio C, Oda M, Tsuchiya M: Microcirculatory disturbances in endotoxin-induced disseminated intravascular coagulation. Adv Exp Med Biol 242: 135-141, 1988.
5. Shibayama Y: Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury. J Pathol 151: 315-321, 1987.
6. Hewett JA, Roth RA: The coagulation system, but not circulating fibrinogen, contributes to liver injury in rats exposed to lipopolysaccharide from gram-negative bacteria. J Pharmacol Exp Ther 272 (1): 53-62, 1995.
7. Pizzo SV, Schwartz ML, Hill RL, McKee PA: Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin. J Clin Invest 51: 2841-2850, 1972.
8. Pearson JM, Roth RA: Thrombin is a critical and distal mediator of LPS-induced liver injury in vivo. [Abstract] Toxicologist 30: (1) 79- 1996.
9. Fenton JW, II., Villanueva GB, Ofosu FA, Marganore JM: Thrombin inhibition by hirudin: how hirudin inhibits thrombin. Haemostasis 21(suppl. 1): 27-31, 1991.
10. Emerson TE, Jr., Fournel MA, Leach WJ, Redens TB: Protection against disseminated intravascular coagulation and death by antithrombin III in the Escherichia coli endotoxemic rat. Circ Shock 21: 1-13, 1987.
11. Gomez C, Paramo JA, Colucci M, Rocha E: Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor. Thromb Haemostas 62: 694-698, 1989.
12. Shenep JL, Barton RP, Morgan KA: Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis 151: 1012-1018, 1985.
13. Baue AE, Chaudry IH: Prevention of multiple systems failure. Surgical Clinics of North America 60(5): 1167-1177, 1980.
14. Baue AE: 22, The setting, sequences, and domino effect. In Van Schaik T (ed): Multiple organ failure. patient care and prevention. St. Louis: Mosby-Year Book, Inc. 1990, pp 421-428.
15. Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DF: Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis 157 (3): 565-568, 1988.
16. Aasen AO: LPS plasma levels in patients. In Schlag G, Redl H, (eds): Pathophysiology of shock, sepsis, and organ failure. Berlin: Springer-Verlag, 1993, pp 417-426.
17. Burrell R: Human responses to bacterial endotoxin. Circ Shock 43: 137-153, 1994.
18. Rietschel ET, Brade H: Bacterial endotoxins. Scientific American 267 (2): 54-61, 1992.
19. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmar AJ, Zahringer U, Seydel U, di Padova F, Schreier M, Brade H: Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8: 217-225, 1994.
20. Sedman PC, Macfie J, Sagar P, Mitchell CJ, May J, Mancey-Jones B, Johnstone D: The prevalence of gut translocation in humans. Gastroenterology 107: 643-649, 1994.
21. Deitch EA: Bacterial translocation of the gut flora. J Trauma 30(12)suppl. S184-S188, 1990.
22. McCuskey RS, McCuskey PA, Urbaschek R, Urbaschek B: Kupffer cell function in host defense. Rev Infect Dis 9(suppl. 5): S616-S619, 1987.
23. Shenep JL, Mogan KA: Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis. J Infect Dis 150 (3): 380-388, 1984.
24. Baumgartner J: Anti-endotoxin therapy and the management of sepsis. J Antimicrob Chemother 29 (4): 360-363, 1992.
25. Fischer E, Marano MA, Van Zee KJ, Rock CS, Hawes AS, Thompson WA, DeForge L, Kenney JS, Remick DG, Bloedow DC, Thompson RC, Lowry SF, Moldawer LL: Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 89: 1551-1557, 1992.
26. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV: Multiple-organ-failure syndrome. Arch Surg 121: 196-197, 1986.
27. Faist E, Meakins J, and Schildberg FW, editors.Host defense dysfunction in trauma, shock and sepsis. Mechanisms and theraputic approaches. Berlin: Springer-Verlag; 1993; 1p.
28. Lorente JA, Garcia-Frade LJ, Landin L, de Pablo R, Torrado C, Renes E, Garcia-Avello A: Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103: 1536-1542, 1993.
29. Fourrier F, Chopin C, Huart J, Runge I, Caron C, Goudemand J: Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104: 882-888, 1993.
30. Fenton JW, II., Bing DH: Thrombin active-site regions. Seminars in Thrombosis and Hemostasis 12(3): 200-208, 1986.
31. Holmsen H, Day HJ: The selectivity of the thrombin-induced platelet release reaction: subcellular localization of released and retained constituents. J Lab Clin Med 75 (5): 840-855, 1970.
32. Siess W: Molecular mechanisms of platelet activation. Physiol Rev 69(1): 58-178, 1989.
33. Venturini CM, Kaplan JE: Thrombin induces platelet adhesion to endothelial cells. Seminars in Thrombosis and Hemostasis 18(2): 275-283, 1992.
34. de Groot PG, Reinders JH, Sixma JJ: Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracullular matrix towards platelets. J Cell Biol 104: 697-704, 1987.
35. DeMichele MAA, Minnear FL: Modulation of vascular endothelial permeability by thrombin. Seminars in Thrombosis and Hemostasis 18(3): 287-295, 1992.
36. Bizios R, Lai L, Fenton JW, II, Malik AB: Thrombin-induced chemotaxis and aggregation of neutrophils. J Cell Physiol 128: 485-490, 1986.
37. Bar-Shavit R, Kahn A, Fenton JW, II., Wilner GD: Chemotactic response of monocytes to thrombin. J Cell Biol 96: 282-285, 1983.
38. Drake WT, Issekutz AC: A role for a-thrombin in polymorphonuclear leukocyte recruitment during inflammation. Seminars in Thrombosis and Hemostasis 18 (3): 333-340, 1992.
39. Cohen WM, Wu H, Leatherstone GL, Jenzano JW, Lundblad RL: Linkage between blood coagulation and inflammation: stimulation of neutrophil tissue kallikrein by thrombin. Biochem Biophys Res Comm 176: 315-320, 1991.
40. Bar-Shavit R, Kahn A, Fenton JW, II., Wilner GD: Receptor-mediated chemotactic response of a macrophage cell line (J774) to thrombin. Lab Invest 49 (6): 702-707, 1983.
41. Kudhal K, Fisker S, Sonne O: A thrombin receptor in resident rat peritoneal macrophages. Exp Cell Res 193: 45-53, 1991.
42. Weyer B, Peterson TE, Sonne O: Characterization of the binding of bovine thrombin to isolated rat hepatocytes. Thromb Haemostas 60 (3): 419-427, 1988.
43. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a fuctional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1068, 1991.
44. Gerszten RE, Chen J, Ishii M, Ishii K, Wang L, Nanevicz T, Turck CW, Vu TH, Coughlin SR: Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature 368: 648-651, 1994.
45. Ishii K, Hein L, Koblika B, Coughlin SR: Kinetics of thrombin receptor cleavage on intact cells. J Biol Chem 268 (13): 9780-9786, 1993.
46. Hui KY, Jakubowski JA, Wyss VL, Angleton EL: Minimal sequence requirement of thrombin receptor agonist peptide. Biochem Biophys Res Comm 184 (2): 790-796, 1992.
47. Hung DT, Vu TH, Nelken NA, Coughlin SR: Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor. J Cell Biol 116 (3): 827-832, 1992.
48. Gaeta GB, Wisse E: Endotoxin effect on the isolated perfused rat liver: functional and ultrastructural observations. J Submicrosc Cytol 15(3): 705-712, 1983.
49. Utili R, Abernathy CO, Zimmerman HJ: Cholestatic effects of Escherichia coli endotoxin on the isolated perfused rat liver. Gastroenterology 70(2): 248-253, 1976.
50. Utili R, Abernathy CO, Zimmerman HJ: Studies on the effects of E. coli endotoxin on canilicular bile formation in the isolated perfused rat liver. J Lab Clin Med 89: 471-482, 1977.
51. Bell WR: 54, Defibrinogenating enzymes. In Colman RW, Hirsh J, Marder VJ, Salzman EW, (eds): Hemostasis and Thrombosis. 2nd ed. Philadelphia: J.B. Lippincott Company, 1982, pp 886-900.
52. Yamanaka H, Nukina S, Handler JA, Currin RT, Lemasters JJ, Thurman RG: Transient activation of hepatic glycogenolysis by thrombin in perfused livers. Eur J Biochem 208: 753-759, 1992.
53. Moon DG, van Der Zee H, Weston LK, Gudewicz PW, Fenton JW, II, Kaplan JE: Platelet modulation of neutrophil superoxide anion production. Thromb Haemostas 63 (1): 91-96, 1990.
54. Hewett JA, Schultze AE, VanCise S, Roth RA: Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab Invest 66(3): 347-361, 1992.
55. Brown AP, Ng H, Jean PA, Ganey PE, and Roth RA. Kupffer cell inactivation protects against lipopolysaccharide-induced hepatic injury despite neutrophil accumulation and tumor necrosis factor-a (TNF-a) release.[Unpublished] 1995;
56. Ganey PE, Schultze AE: Depletion of neutrophils and modulation of Kupffer cell function in allyl alcohol-induced hepatotoxicity. Toxicology 99: 99-106, 1995.
57. Dean PB, Neimi P, Kivisaari L, Kormano M: Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride. Invest Radiol 23 (suppl 1): S258-S260, 1988.
58. Hardonk MJ, Dijkhuis FWJ, Hulstaert CE, Koudstaal J: Heterogeneity of rat liver and spleen macrophages in gadolinium choloride-induced elimination and repopulation. J Leukoc Biol 52: 296-302, 1992.
59. Glusa E: Vascular effects of thrombin. Seminars in Thrombosis and Hemostasis 18(3): 296-303, 1992.
60. Connolly TM, Condra C, Feng D, Cook JJ, Straneri MT, Reilly CF, Nutt RF, Gould RJ: Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb Haemostas 72 (4): 627-633, 1994.
61. Jaeschke H, Farhood A, Smith CW: Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 21: G1051-G1056, 1991.
62. Larsen GL, Parrish DA, Henson PM: Lung defense the paradox of inflammation. Chest 5: 1-5, 1983.
63. Ganey PE, Bailie MB, VanCise S, Colligan
ME, Madhukar BV, Robinson JP, Roth RA: Activated neutrophils from rat
injured isolated hepatocytes. Lab Invest 70(1): 53-60, 1994.
